Financing

Digital health firm Biofourmis adds another $20m to its funding pot

One of the digital health sector’s latest unicorn companies – Biofourmis – has upscaled its recent fourth round financing, adding $20 million to the $300 million it raised in April. The top-up comes from Intel Capital, the strategic investment arm of chipmaker Intel, and has been announced alongside two new additions to Biofourmis’ board of …

Digital health firm Biofourmis adds another $20m to its funding pot Read More »

Chinese biotech Sironax raises $200m for RIPK1 pipeline

Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire to back companies working on RIPK1 inhibitors despite setbacks for GSK in the class. The five-year-old Chinese company – which is developing drugs for age-related degenerative diseases – said it will use the proceeds of the Series …

Chinese biotech Sironax raises $200m for RIPK1 pipeline Read More »

Report finds UK risks falling behind rivals in life sciences

A just-published report on the UK’s life sciences sector “ought to ring alarm bells across government,” according to the Association of the British Pharmaceutical Industry (SBPI). The Life Sciences Competitiveness Indicators report shows that spending on life sciences R&D was £2.7 billion in 2020 – accounting for 0.12% of GDP and ranked third among the …

Report finds UK risks falling behind rivals in life sciences Read More »

CAMP4 raises $100m to take lead RNA drugs into clinic

Armed with a $100 million second-round financing, CAMP4 Therapeutics is preparing to start the first clinical trial of a drug targeting regulatory RNA (regRNA) molecules that can be used to fine-tune the expression of genes. The Cambridge, Massachusetts biotech has discovered that areas of the non-coding parts of the human genome – referred to by …

CAMP4 raises $100m to take lead RNA drugs into clinic Read More »

Cancer Research UK partnership aims to back 10 new startups

Cancer Research UK has expanded an alliance with investment group Deep Science Ventures with a commitment to support the formation up to 10 new oncology startups. London-based DSV has been working since 2019 with the charity’s Cancer Research Horizons unit, an incubator organisation which was set up to nurture new discoveries in academia and help …

Cancer Research UK partnership aims to back 10 new startups Read More »

Digital health financing falls to two-year low in first half

The buoyant financing environment for digital health companies that took off during the pandemic looks like it had come to an end, according to new figures from market watcher Rock Health. The influx of cash that flowed into the sector during the COVID-19 crisis has been followed by a correction that was starting to appear …

Digital health financing falls to two-year low in first half Read More »

Blueprint cashes in on the past to build its future

Blueprint Medicines has taken an unusual route to raising cash for its R&D pipeline – selling off some of the royalties from its already-approved medicines in return for a cash injection of up to $1.25 billion. The targeted cancer drug specialist has sold its interest in tyrosine kinase inhibitor Ayvakit/Ayvakyt (avapritinib) and Roche-partnered RET inhibitor …

Blueprint cashes in on the past to build its future Read More »

FAQs on Medicare Financing and Trust Fund Solvency

In discussions of Medicare’s financial condition, attention frequently centers on one specific measure—the solvency of the Medicare Hospital Insurance (HI) trust fund, out of which Medicare Part A benefits are paid. Based on current projections from the Medicare Board of Trustees, the HI trust fund is projected to be depleted in 2028, six years from …

FAQs on Medicare Financing and Trust Fund Solvency Read More »

HiDoc raises $7m and names new CEO as digital tool for IBS launches

HiDoc Technologies has secured a cash injection of $7 million to help with the launch of its Cara Care digital therapeutic for people with irritable bowel syndrome (IBS), and fund a move into additional therapeutic categories. Use of the funding – which takes the total raised by the German digital health company to $16 million …

HiDoc raises $7m and names new CEO as digital tool for IBS launches Read More »

AI specialist Insilico raises $60m as more projects head to clinic

Insilico Medicine has raised $60 million in fourth-round financing that will help to fund the advancement of more drugs towards the clinical testing stage. The Hong Kong-based startup – one of an emerging crop of companies which are using artificial intelligence platforms to discover and design new therapeutic compounds – took its first drug into …

AI specialist Insilico raises $60m as more projects head to clinic Read More »

SwanBio raises $56m for rare neurological disease gene therapy

SwanBio Therapeutics has raised $56 million in a second-round financing that will be used to advance its lead gene therapy candidate for adrenomyeloneuropathy (AMN) into clinical testing later this year. The Series B takes the total raised by the Philadelphia-based biotech to $133 million and is earmarked for a phase 1/2 trial of the gene …

SwanBio raises $56m for rare neurological disease gene therapy Read More »

Mental health record specialist Osmind raises $40 million

US digital health firm Osmind – which had developed an electronic health record (EHR) system for patients with mental illness – has added to its finances with a $40 million Series B financing. The San Francisco-based company says it will use the proceeds of the financing to expand its workforce and make improvements to its …

Mental health record specialist Osmind raises $40 million Read More »

KFF Analysts Find That Between 5.3 Million and 14.2 Million People Could Lose Medicaid Coverage Following the End of the Public Health Emergency and Continuous Enrollment Requirement, With an Unknown Number Able to Find New Coverage

The Enrollment Growth is Expected to Cost States Over $47 Billion Through FY 2022, But States Will Have Received $100 Billion to Cover New Medicaid Costs and Provide Additional General Fiscal Relief Between 5.3 million and 14.2 million low-income people could lose Medicaid coverage following the end of the public health emergency and federal continuous…More

Fiscal and Enrollment Implications of Medicaid Continuous Coverage Requirement During and After the PHE Ends

This analysis projects enrollment growth through the end of FY 2022. It examines how much of the enrollment growth can be attributed to baseline, or expected enrollment increases without the pandemic, and how much to the MOE continuous enrollment requirement during the PHE. We explore the costs tied to MOE enrollment growth, estimate how much …

Fiscal and Enrollment Implications of Medicaid Continuous Coverage Requirement During and After the PHE Ends Read More »

Ex-Sanofi CEO backs first European biomanufacturing SPAC

A new “black cheque” company that claims to be the first in Europe devoted to biomanufacturing has been set up by a team of investors, including former Sanofi chief executive Gerard le Fur. The new company – dubbed eureKING –  plans to raise €150 million ($158 million) that will be used to buy up companies …

Ex-Sanofi CEO backs first European biomanufacturing SPAC Read More »

Curebase bags $40m to develop patient-centric trials platform

Curebase has raised $40 million in second-round financing that will help it run more complex interventional trials for its biopharma clients, according to chief executive Tom Lemberg. The Series B takes the total raised by Curebase to $59 million since it was set up five years ago to develop a patient-focused approach to clinical research, …

Curebase bags $40m to develop patient-centric trials platform Read More »

DTx firm Sidekick eyeing new partnerships after $55m round

Sidekick Health is already working with pharma heavyweights Pfizer and Bayer on gamified apps that can be paired with drug therapies to improve patient outcomes – and says it is poised to announce three more in the coming months. The Iceland-based digital health company – which has just raised $55 million in second-round funding – …

DTx firm Sidekick eyeing new partnerships after $55m round Read More »

Digital health firm Hello Heart raises $70m

Hello Heart has raised $70 million in fourth-round financing to help grow its smartphone-based technology for people seeking to improve their heart health. Hello Heart blood pressure monitor Hello Heart’s digital platform is based on a blood pressure monitor and smartphone app. It deploys artificial intelligence to help users track their blood pressure, pulse rate, …

Digital health firm Hello Heart raises $70m Read More »

Google, Sanofi back UK biotech OMass’ $100m second round

OMass Therapeutics has raised an impressive $100 million in a Series B financing that is said to be the largest ever for a UK biotech focusing on small-molecule drug development. The Oxford-based company said the financing, led by venture capital arms of Google and Sanofi as well as Northpond Ventures, will be used to bring …

Google, Sanofi back UK biotech OMass’ $100m second round Read More »

Biofourmis is digital health’s latest unicorn, after raising $300m

Biofourmis has raised $300 million in fourth-round financing, sending its value rocketing to around $1.3 billion and injecting some fresh momentum into the digital health sector after a slowdown in fundraising in the first quarter. The Boston-based startup – which has a business model straddling digital therapeutics (DTx), artificial intelligence-powered patient management and provision of …

Biofourmis is digital health’s latest unicorn, after raising $300m Read More »

Sarepta DMD rival PepGen files $115m IPO

Just days after dosing its first patient in a Duchenne muscular dystrophy trial, US biotech PepGen has pushed the button on an initial public offering (IPO). The Boston-based company has filed with the US Securities and Exchange Commission to raise up to $115 million from the IPO, according to a Renaissance Capital report. The funding …

Sarepta DMD rival PepGen files $115m IPO Read More »

Gaming health firm GripAble raises $11m for rehab platform

GripAble has raised $11 million in first-round financing that will be used to advance its digital health approach to rehabilitation for people with neurological and musculoskeletal conditions on the international stage. The London, UK-based company has developed a platform that combines a hand-held sensor, gamified mobile app software, and telehealth consultations with therapists, which is …

Gaming health firm GripAble raises $11m for rehab platform Read More »

Medicaid Spending and Enrollment: Updated for FY 2022 and Looking Ahead to FY 2023

In February 2022, the Kaiser Family Foundation (KFF) and Health Management Associates (HMA) fielded a rapid, mini-survey of Medicaid directors in all 50 states and the District of Columbia as a follow-up to the annual Medicaid Budget Survey conducted in summer 2021. This brief explores Medicaid enrollment and spending growth estimates for FY 2022 and …

Medicaid Spending and Enrollment: Updated for FY 2022 and Looking Ahead to FY 2023 Read More »

Pharma-backed antibiotic fund makes first investments

Two years after it was first proposed and a year after it officially launched, the pharma-backed AMR Action Fund has made its first investments in companies trying to tackle the pressing problem of antibiotic resistance. The Fund – set up as a public-private partnership by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) – …

Pharma-backed antibiotic fund makes first investments Read More »

AXA beefs up life sciences investments with $500m push

Multinational insurance company AXA has launched a new €440 million ($500 million) drive to provide private equity investments in healthcare companies that deepens its interest in the life sciences sector. Until now, AXA Investment Managers has been focused more on the delivery end of health care – health centres and private hospitals, for example – …

AXA beefs up life sciences investments with $500m push Read More »

Sano raises $11m for patient and trial matchmaking platform

UK startup Sano Genetics has raised $11 million in first-round financing to develop its go-between service, which aims to overcome one of the big challenges in clinical research by connecting patients with trial sponsors. The Cambridge-based company said the new funding – which adds to around $4 million in seed financing – will be used …

Sano raises $11m for patient and trial matchmaking platform Read More »

Domestic HIV Funding in the White House FY 2023 Budget Request

President Biden released his full FY 2023 budget request on March 28, 2022. The President’s second budget request builds on past efforts to address the domestic HIV response, including by proposing funding increases for the “Ending the HIV Epidemic” (EHE) initiative. The EHE was launched by the Trump Administration in 2019, building on efforts made…More

GSK partners LifeMine on fungi-derived medicines

GlaxoSmithKline has thrown its financial and drug development weight behind LifeMine Therapeutics, a US startup that aims to find new therapeutics from fungi – widely regarded as an underexplored resource of biologically-active compounds. There’s a rich history of finding useful medicines from fungi, from the antibiotic penicillin to immune suppressant cyclosporine and cholesterol drug lovastatin. …

GSK partners LifeMine on fungi-derived medicines Read More »

Sanofi backs precision oncology firm Nucleai in $33m fundraising

Israeli startup Nucleai has raised $33 million in a second-round financing that will be used to further its work on using artificial intelligence and spatial biology to find biomarkers that can predict which patients will respond to cancer treatments. The five-year-old company uses machine vision and learning technology originally developed for military applications to predict …

Sanofi backs precision oncology firm Nucleai in $33m fundraising Read More »

Belgium’s Precirix raises €80m to fund radiopharma aspirations

Precirix has raised €80 million ($88 million) in a second-round financing that will be used to advance multiple radiopharmaceutical candidates for cancer through clinical development. The Belgian biotech, which was spun out from the Vrije Universiteit Brussel in 2014, is developing a pipeline of radio-labelled, single-chain antibodies led by CAM-H2, currently in a phase 1/2 …

Belgium’s Precirix raises €80m to fund radiopharma aspirations Read More »

Scenic Bio raises $31m for genetic modifier platform

18 months after signing its first partnering deal with Genentech, Scenic Biotech has raised $31 million in first-round financing that it will use to take its own genetic modifier-targeted medicines into clinical trials. The Netherlands-based biotech, which is putting together a pipeline of genetic modifier drugs for cancer and rare diseases, said the new funding …

Scenic Bio raises $31m for genetic modifier platform Read More »

Boehringer backs AI-powered anti-infective startup ArrePath

A new company set up to use machine learning to find new anti-infective drugs – ArrePath – has launched onto the scene with $20 million in seed financing from a group of investors including the Boehringer Ingelheim Venture Fund. The Princeton, New Jersey-based startup will use the funding to develop its artificial intelligence and imaging …

Boehringer backs AI-powered anti-infective startup ArrePath Read More »

The Impact of the COVID-19 Recession on Medicaid Coverage and Spending

Unlike previous recessions in modern history, this past recession was spurred by the spread of a virus (COVID-19), which created a public health crisis with unique health implications. This brief describes the broader impacts of this most recent recession – which lasted from February 2020 to April 2020 — and also explores how trends in …

The Impact of the COVID-19 Recession on Medicaid Coverage and Spending Read More »

MindMaze raises $105m to seek out new neurological DTx

Swiss digital health company MindMaze has raised $105 million to help take its digital therapeutics (DTx) for neurological diseases like stroke onto the global stage, and fund the development of therapies for other diseases like Alzheimer’s and Parkinson’s. MindMaze takes a gaming approach to its DTx platform, but goes well beyond the use of a …

MindMaze raises $105m to seek out new neurological DTx Read More »

Vaccines upstart Curevo has designs on blockbuster GSK franchise

Seattle, US vaccine startup Curevo has raised $60 million in first-round financing that it says will be used to run head-to-head trials of its experimental shingles vaccines CRV-101 and GlaxoSmithKline’s market-leading Shingrix. The cash will fund a phase 2b trial in 678 people aged over 50 that will compare CRV‑101’s immunogenicity and safety profile relative …

Vaccines upstart Curevo has designs on blockbuster GSK franchise Read More »

Ada raises another $30m to push symptom checker in US

Germany’s Ada Health has added another $30 million to its second-round financing first announced last year, saying it will use the new cash to strengthen its presence in the US market. The Berlin-based digital health company – best known for its app to help patients diagnose conditions from symptoms – opened the Series B with …

Ada raises another $30m to push symptom checker in US Read More »

Pharmacy group 1000Farmacie closes $15m financing round

Italian online pharmacy group 1000Farmacie has raised €15 million In one of the largest first-round financings in the digital health category. The company – which brings together more than 100 Italian pharmacies using a common, full-service online platform – will use the new funding to expand its network as well as the range of services …

Pharmacy group 1000Farmacie closes $15m financing round Read More »

Medicaid Financing and the U.S. Territories: Implications of The Build Back Better Act

The U.S territories have faced an array of longstanding fiscal and health challenges that were exacerbated by recent natural disasters and the COVID-19 pandemic. This policy watch examines how Medicaid funding for the territories works, the current allotments, and how the Build Back Better Act (BBA) would change Medicaid funding for the territories going forward. …

Medicaid Financing and the U.S. Territories: Implications of The Build Back Better Act Read More »

Digital health funding boom continues as ETAO cuts SPAC deal

Chinese digital health firm ETAO International will go public via a merger with a blank cheque company that will value it at around $2.5 billion. The deal with special purpose acquisition company (SPAC) Mountain Crest Acquisition Corp III (MCAE) will give the five-year-old telehealth group up to $304 million in gross proceeds, bolstered by a …

Digital health funding boom continues as ETAO cuts SPAC deal Read More »

Offshore warning as UK biotech investment rises sharply in 2021

2021 was a record year for investments in UK biotech companies, consolidating the country’s position as one of Europe’s top life science hubs and apparently shrugging off the effects of the pandemic and Brexit. All told, the sector raised £4.5 billion ($6 billion) in public and private financings during the year, almost two-third (60%) up …

Offshore warning as UK biotech investment rises sharply in 2021 Read More »

Health gaming firm Akili takes blank cheque route to public listing

Akili Interactive has agreed a merger with special purpose acquisition company (SPAC) Social Capital Suvretta Holdings Corp I in a deal that will take it into public hands with a valuation of around $1 billion. The digital health company, which developed the first prescription gaming app to be approved by the FDA, will swell its …

Health gaming firm Akili takes blank cheque route to public listing Read More »

Digital health firms nab record $57.2bn funding in 2021; report

The final numbers are in, and now it’s official – digital health companies raked in a massive $57.2 billion in funding last year, beating prior records with a 79% increase over 2020. The data from CB Insights’ annual State of Digital Health report notes that the record investments were apparent across all geographies and were …

Digital health firms nab record $57.2bn funding in 2021; report Read More »

PolyPhotonix raises $10m to trial sleep mask for diabetic eye disease

The UK company behind a sleep mask that aims to treat sight-robbing complications of diabetes has secured $10 million in funding that will be used to run trials of the medical device. PolyPhotonix secured the money in a first-round financing led by Prevail InfoWorks, a company specialising in management of clinical trial data, with the …

PolyPhotonix raises $10m to trial sleep mask for diabetic eye disease Read More »

Otsuka backs GrayMatters’ digital wearable tech for mental disorders

Japanese pharma group Otsuka has led a $10 million first-round financing of GrayMatters Health, an Israeli company developing a digital health approach to the management of mental illness. Otsuka Medical Devices is also taking some rights to GrayMatters’ platform – called Prism – in Japan and some other Asian countries in connection with the financing, …

Otsuka backs GrayMatters’ digital wearable tech for mental disorders Read More »

Merck backs startup bringing AI to fertility treatment

It’s no secret that fertility treatment is expensive and has a low success rate, placing a big financial and emotional burden on would-be parents. Now, a Canadian biotech aims to tackle that problem though the use of artificial intelligence. Toronto-based Future Fertility has developed an AI called Violet that it says can predict the viability …

Merck backs startup bringing AI to fertility treatment Read More »

Bond Digital Health raises £1m for lateral flow test software

Welsh medtech company Bond Digital health has raised £1 million ($1.3 million) in additional funding for its data capture and management system for lateral flow tests (LFTs). The Cardiff-based company said  it will use the new money to expand its headcount, including hiring a new customer service team, and adding to its sales, marketing and …

Bond Digital Health raises £1m for lateral flow test software Read More »

Boehringer invests again in AI diagnosis specialist Brainomix

UK digital health company Brainomix has raised £16 million ($21.5 million) that will be used to extend the use of its artificial intelligence-based medical imaging software for stroke to new therapeutic areas. The Oxford University spinout – which has said that AI and machine learning is set to become the “driving force” behind imaging diagnostics …

Boehringer invests again in AI diagnosis specialist Brainomix Read More »

Remote care specialist Cadence worth $1bn after raising $100m

Digital health startup Cadence has reached a heady $1 billion valuation just a few months after launch, thanks to a $100 million financing. The latest round, led by Coatue Management, comes just four months after Cadence came out of stealth mode with $41 million in backing for its remote care management platform that allows doctors …

Remote care specialist Cadence worth $1bn after raising $100m Read More »

Digital health firm Pear goes public, raising $175 million

Pear Therapeutics has completed its merger with blank cheque company Thimble Point Acquisition Corp, claiming a Nasdaq listing and raising $175 million in gross proceeds for the digital health specialist. Pear will make its debut on the exchange today after combining with Thimble Point – a special purpose acquisition company (SPAC) – in a deal …

Digital health firm Pear goes public, raising $175 million Read More »

Build Back Better Would Reduce Disproportionate Share Hospital (DSH) Payments and Limit Uncompensated Care (UCC) Pools in Non-Expansion States

The Build Back Better (BBB) Act proposes reducing disproportionate share hospital (DSH) allotments by 12.5% starting in federal fiscal year (FFY) 2023 and places limits on Medicaid uncompensated care (UCC) pools for non-expansion states. This policy watch explains what these payments are, what changes have been tied to the ACA, and examines potential implications of …

Build Back Better Would Reduce Disproportionate Share Hospital (DSH) Payments and Limit Uncompensated Care (UCC) Pools in Non-Expansion States Read More »

Sanofi winds $40m into UK gene therapy firm Gyroscope

French drugmaker Sanofi has made a $40 million investment in Gyroscope Therapeutics, with another $20 million potentially on offer as the UK biotech advances its clinical-stage gene therapies for ophthalmic diseases. The investment gives Sanofi rights of first refusal on GT005, Gyrocope’s lead gene therapy for geographic atrophy (GA) secondary to age-related macular degeneration (AMD), …

Sanofi winds $40m into UK gene therapy firm Gyroscope Read More »

Blackstone revs up Autolus’ CAR with $250m fuel injection

Private equity firm Blackstone has agreed to provide up to $250 million in financing to UK biotech Autolus Therapeutics, to help it take acute lymphoblastic leukaemia (ALL) CAR-T therapy obe-cel through late-stage development. The deal includes a $100 million equity stake, $50 million in financing as soon as it closes, and another $100 million on …

Blackstone revs up Autolus’ CAR with $250m fuel injection Read More »

Digital health firm Better Therapeutics makes Nasdaq debut

Better Therapeutics has joined the ranks of publicly-listed digital health companies after completing a merger with blank cheque company Mountain Crest Acquisition Corp II. The company, which specialises in prescription digital therapeutics (DTx) for cardiometabolic diseases, listed on the Nasdaq under the BTTX ticker late on Friday. Shares initially fell back slightly from an opening …

Digital health firm Better Therapeutics makes Nasdaq debut Read More »

Hinge Health valuation tops $6bn after $600m funding round

Hinge Health has become one of the top-valued companies in the digital health sector after securing a whopping $600 million in a fifth financing round. The San Francisco-based company – which provides digital tools for managing musculoskeletal (MSK) conditions like back and joint pain – is now valued at around $6.2 billion, more than twice …

Hinge Health valuation tops $6bn after $600m funding round Read More »

Industry welcomes boost to health research in UK budget

Groups representing the biopharma industry have welcomed an increase in health-specific R&D to £5 billion in the UK autumn budget, despite a longer timeline for reaching the target of £22 billion in overall R&D spending. The Association of the British Pharmaceutical Industry (ABPI) and BioIndustry Association (BIA) both said that the increase acknowledges the enormous …

Industry welcomes boost to health research in UK budget Read More »

States Respond to COVID-19 Challenges but Also Take Advantage of New Opportunities to Address Long-Standing Issues: Results from a 50-State Medicaid Budget Survey for State Fiscal Years 2021 and 2022

This report provides an in-depth examination of the changes taking place in Medicaid programs across the country. The findings are drawn from the 21st annual budget survey of Medicaid officials in all 50 states and the District of Columbia conducted by KFF and Health Management Associates (HMA), in collaboration with the National Association of Medicaid …

States Respond to COVID-19 Challenges but Also Take Advantage of New Opportunities to Address Long-Standing Issues: Results from a 50-State Medicaid Budget Survey for State Fiscal Years 2021 and 2022 Read More »

Medicaid Enrollment & Spending Growth: FY 2021 & 2022

This issue brief provides an overview of Medicaid spending and enrollment growth with a focus on state fiscal years 2021 and 2022. Findings are based on data provided by state Medicaid directors as part of the 21st annual survey of Medicaid directors in states and the District of Columbia conducted by KFF and Health Management …

Medicaid Enrollment & Spending Growth: FY 2021 & 2022 Read More »

Potential Costs and Impact of Health Provisions in the Build Back Better Act

A summary of 10 of the major health coverage and financing provisions of the original Build Back Better Act, with discussion of the potential implications for people and the federal budget.

UK startup Leucid raises £11.5m for solid tumour CAR-T therapies

CAR-T therapies have revolutionised the treatment of some blood cancers, but so far haven’t been able to repeat that success in solid tumours. UK startup Leucid Bio hopes to change that – and has just raised £11.5 million in first-round financing to take its plans forward. The London-based biotech has been set up to develop …

UK startup Leucid raises £11.5m for solid tumour CAR-T therapies Read More »

AI specialist Exscientia raises $510m in upsized IPO, placing

Exscientia’s artificial intelligence-based drug discovery engine is still largely unproven, but that hasn’t stopped the company raking in funding from investors keen to back its platform. The final numbers are now in from its recently announced initial public offering on the US Nasdaq, and the numbers are impressive, swelling from an initially forecast $304 million …

AI specialist Exscientia raises $510m in upsized IPO, placing Read More »

Oxford Nanopore makes stellar debut on UK stock market

Shares in DNA sequencing specialist Oxford Nanopore rocketed after the company made its debut on the London Stock Exchange yesterday, rising nearly 50% to propel its valuation up towards the £5 billion ($6.7 billion) mark. The Oxford University spinout saw its share price rise from an opening of 425p to 612p by close of trading …

Oxford Nanopore makes stellar debut on UK stock market Read More »

YonaLink, TrialJectory get $1m grant for patient recruitment tool

Two digital health companies – YonaLink and TrialJectory – have received a grant to develop a tool designed to make it easier and quicker to enrol patients into clinical trials. The grant from the Israel-US Binational Industrial Research and Development (BIRD) Foundation will go towards the further development of the platform, which automates the conduct …

YonaLink, TrialJectory get $1m grant for patient recruitment tool Read More »

Rome Therapeutics raises $77m for junk DNA-targeting drugs

Startup Rome Therapeutics has raised $77 million in second-round financing to help mine sequences of DNA – which were dismissed for years as ‘junk’ – for hidden treasure. The Cambridge, Massachusetts biotech is focusing specifically on the 60% of DNA sequences that repeat themselves hundreds or thousands of times in the genome, known as the …

Rome Therapeutics raises $77m for junk DNA-targeting drugs Read More »

Implications of the Medicaid Fiscal Cliff for the U.S. Territories

The U.S territories – American Samoa, the Commonwealth of the Northern Mariana Islands (CNMI), Guam, Puerto Rico, and the U.S. Virgin Islands (USVI) – have faced an array of longstanding fiscal and health challenges that were exacerbated by recent natural disasters and most recently by the COVID-19 pandemic. Differences in Medicaid financing, including a statutory …

Implications of the Medicaid Fiscal Cliff for the U.S. Territories Read More »

Startup Neuroglee raises $10m for virtual neurology clinics

A digital health company focusing on neurodegenerative disorders – Neuroglee Therapeutics – has raised $10 million in first-round funding to roll out a virtual neurology clinics for people with cognitive problems caused by dementia. The Singapore startup, which is partnering with the Mayo Clinic on the clinics, said the cash injection will also go towards …

Startup Neuroglee raises $10m for virtual neurology clinics Read More »

Gates Foundation ramps up funding to Exscientia in COVID project

The Bill & Melinda Gates Foundation must have liked what it saw in an initial collaboration with Exscientia to find new antivirals for COVID-19 and related diseases. Two months after providing initial funding of $1.5 million to get the ball rolling, the philanthropic organisation has now pledged $35 million in funding to a four-year project …

Gates Foundation ramps up funding to Exscientia in COVID project Read More »

Funding round swells digital health firm Whoop’s value to $3.6bn

Fitness wearable company Whoop has raised another $200 million in funding that will help fund its expansion into international markets – and take on deep-pocketed rivals like Amazon, Apple and Google. The sixth-found financing was led by SoftBank’s Vision Fund 2, taking the total raised by the company to date to around $400 million, and …

Funding round swells digital health firm Whoop’s value to $3.6bn Read More »

India’s Breathe Well-being raises $5.5m for diabetes reversal app

Digital health startup Breathe Well-being has raised $5.5 million in first-round financing, which it will use to scale up its clinical tool that it says helps people “prevent, manage and reverse type 2 diabetes.”  The Series A – led by US venture capital group Accel with participation from General Catalyst and Scott Shleifer, global managing …

India’s Breathe Well-being raises $5.5m for diabetes reversal app Read More »

Mahana raises $61m for digital therapeutic for IBS

Mahana Therapeutics has raised second-round financing of $61 million that will be used to launch what it says will be the first prescription digital therapeutics (DTx) for irritable bowel syndrome, one of several digital health products in its pipeline. The Mahana IBS tool – a three-month course that uses cognitive behavioural therapy (CBT) to log …

Mahana raises $61m for digital therapeutic for IBS Read More »

Direct Care Workforce Shortages Have Worsened in Many States During the Pandemic, Hampering Providers of Home and Community-Based Services

During the pandemic many states have experienced worsening direct care workforce shortages that have affected providers of home- and community-based long-term care services (HCBS), according to early findings of a new KFF survey of Medicaid HCBS programs in all 50 states and the District of Columbia. Most states reported workforce shortages as the pandemic’s primary…More

State Medicaid Home & Community-Based Services (HCBS) Programs Respond to COVID-19: Early Findings from a 50-State Survey

This issue brief presents early findings from the most recent KFF survey of Medicaid HCBS programs in all 50 states and the District of Columbia. It focuses on state policies adopted in response to challenges posed by the pandemic, the pandemic’s impact on Medicaid HCBS enrollees and providers, and states’ initial plans for the new …

State Medicaid Home & Community-Based Services (HCBS) Programs Respond to COVID-19: Early Findings from a 50-State Survey Read More »

Digital mental health specialist Woebot raises $90m

Investments in digital health firms are running high at the moment, and a $90 million round for four-year-old Woebot and its artificial intelligence-powered platform for people with mental health ties firmly into that trend. The California-based startup has now raised $114 million from investors, and says it will use the new cash injection to further …

Digital mental health specialist Woebot raises $90m Read More »

Dopavision raises €12m for DTx to tackle myopia epidemic

Digital therapeutics (DTx) startup Dopavision has raised funding to develop its lead product, an app designed to slow the progression of myopia – or short-sightedness – in children or adolescents. The €12 million series round, led by Seventure Partners and backed by investors including Novartis, Boehringer Ingelheim and Abbax Health, will be used to fund …

Dopavision raises €12m for DTx to tackle myopia epidemic Read More »

Digital health investment has skyrocketed; now expect consolidation

A record $14.7 billion in investments was injected into US digital health companies in the first half of this year, overtaking the entire amount raised in 2020 in just six months. The half saw no fewer than 372 deals with an average size of almost $40 million, with 59% of them worth more than $100 …

Digital health investment has skyrocketed; now expect consolidation Read More »

Ambrx tries another IPO as it chases down HER2 rivals

California biotech Ambrx Biopharma is hoping to raise $126 million from a listing on the New York Stock Exchange (NYSE) that will be used in part to fund clinical development of ARX-788, its HER2-targeting antibody drug conjugate (ADC). The Scripps Research spinout could be just 18 months away from licensee NovoCodex reporting results of a …

Ambrx tries another IPO as it chases down HER2 rivals Read More »

Dermavant raises $200m to ease launch of Otezla rival tapinarof

Dermavant is in line to make some big payments to GlaxoSmithKline if its topical psoriasis drug tapinarof reaches the market, and it has just cut a deal to defray those costs. The Roivant group company has raised $160 million from investors plus a $40 million credit facility that it can draw on if – and …

Dermavant raises $200m to ease launch of Otezla rival tapinarof Read More »

Babylon Health may go public via blank cheque company merger; report

Digital health player Babylon Health is exploring a merger with a so-called ‘blank cheque’ company as a route to a public listing, according to a Swedish investment group. Kinnevik AB – which holds a 16% stake in Babylon – said that a transaction with a special-purpose acquisition company (SPAC) is being explored and may or …

Babylon Health may go public via blank cheque company merger; report Read More »

Bayer backs Ada Health’s symptom checker app in $90m financing

Ada Health has received another endorsement for its app to help patients diagnose conditions from symptoms, raising an impressive $90 million in funding from investors including the venture capital arm of Bayer.  Leaps by Bayer was joined by Samsung Catalyst Fund, Vitruvian Partners, Inteligo Bank, F4 and Mutschler Ventures in the second-round financing of the …

Bayer backs Ada Health’s symptom checker app in $90m financing Read More »

Akili raises $110m to build its digital therapeutics pipeline

Digital health player Akili has raised $110 million fourth-round funding, backed by a number of pharma groups, as it works towards extending its product range beyond its flagship EndeavorRx app. EndeavorRx became the first and so far only approved prescription video game treatment in the US when it was cleared by the FDA last year …

Akili raises $110m to build its digital therapeutics pipeline Read More »

The Pandemic Has Exacerbated Long-Standing Health Care Challenges Faced By Puerto Rico and Other U.S. Territories as the End of Temporary Federal Medicaid Funding Approaches

A new KFF analysis examines how the coronavirus pandemic is affecting U.S. territories as well as issues related to the upcoming expiration of temporary Medicaid funding for the territories at the end of September. Prior to the pandemic, the U.S territories –– American Samoa, the Commonwealth of the Northern Mariana Islands (CNMI), Guam, Puerto Rico,…More

Challenges in the U.S. Territories: COVID-19 and the Medicaid Financing Cliff

More than a year into the public health emergency, the COVID-19 pandemic continues to impact the lives of Americans including those living in the U.S. territories. Differences in Medicaid financing, including a statutory cap and match rate, have contributed to broader fiscal and health systems challenges for the territories. While additional federal funds have been …

Challenges in the U.S. Territories: COVID-19 and the Medicaid Financing Cliff Read More »

Healios raises £7m to expand digital mental health services

Digital therapy specialist Healios has raised £7 million in new financing that will be used to expand its suite of mental health services, at a time when demand is soaring in the NHS. The London-based company has developed a virtual care platform that delivers a range of services targeted at children and young people with …

Healios raises £7m to expand digital mental health services Read More »

Breaking Down the U.S. Global Health Budget by Program Area

The U.S. government is the largest donor to global health in the world. This fact sheet breaks down the U.S. global health budget by program area: HIV/PEPFAR; tuberculosis (TB); malaria/the President’s Malaria Initiative (PMI); the Global Fund to Fight AIDS, Tuberculosis, and Malaria; maternal & child health (MCH); nutrition; family planning & reproductive health (FP/RH); …

Breaking Down the U.S. Global Health Budget by Program Area Read More »

Medicaid and State Financing: Key Indicators to Watch Through Pandemic and Recovery

The health and economic effects of the pandemic have significant implications for state Medicaid programs. More people become eligible and enroll in Medicaid during economic downturns; at the same time, states may face declines in revenues. This brief presents the most current data for key indicators to help understand how various economic factors that could …

Medicaid and State Financing: Key Indicators to Watch Through Pandemic and Recovery Read More »

Aura raises $80m to develop its virus-like cancer drugs

US biotech Aura Biosciences has closed an oversubscribed financing, raising $80 million to help take its lead virus-like drug conjugate (VDC) for a cancer that affects the eye into late-stage development. The Cambridge, Massachusetts-based company is currently testing belzupacap sarotalocan (AU-011) in a phase 2 trial involving patients with choroidal melanoma, a tumour that develops …

Aura raises $80m to develop its virus-like cancer drugs Read More »

Welsh startup Antiverse raises $2m for antibody discovery toolkit

New biotech Antiverse has raised seed funding of £1.4 million ($2 million) to develop its artificial intelligence-based platform for discovering therapeutic antibodies. The Cardiff, Wales startup is combining machine learning and phage display techniques to model antibody-antigen binding and says it can cut the time it takes to develop a drug candidate. It’s one of …

Welsh startup Antiverse raises $2m for antibody discovery toolkit Read More »

Medicaid Spending and Enrollment Trends Amid the COVID-19 Pandemic – Updated for FY 2021 & Looking Ahead to FY 2022

Even as the COVID-19 vaccine roll-out is accelerating across the country, the public health and economic effects of the pandemic continue to put pressure on Medicaid spending and enrollment. In mid-February 2021, the Kaiser Family Foundation (KFF) and Health Management Associates (HMA) fielded a two-part rapid, mini-survey of Medicaid directors in all 50 states and …

Medicaid Spending and Enrollment Trends Amid the COVID-19 Pandemic – Updated for FY 2021 & Looking Ahead to FY 2022 Read More »

State Variation in Medicaid LTSS Policy Choices and Implications for Upcoming Policy Debates

This brief takes a closer look at multiple measures beyond waiver waiting lists to evaluate state choices about optional Medicaid eligibility pathways, spending, and services for seniors and people with disabilities as of 2018. The analysis draws on several KFF resources, including 50-state surveys of Medicaid financial eligibility pathways for seniors and people with disabilities, …

State Variation in Medicaid LTSS Policy Choices and Implications for Upcoming Policy Debates Read More »

Innovaccer gains unicorn status, plans to launch cloud platform

The health technology company’s valuation skyrocketed to $1.3 billion following its latest funding round. It plans to use the new funds to launch Innovaccer Health Cloud, which will aggregate and normalize data from different systems and support the development of interoperable apps.

Two New Analyses: House COVID-19 Relief Plan Would Temporarily Lower Marketplace Premiums for Millions and More than Offset Short-Term State Costs to Expand Their Medicaid Programs

The House COVID-19 relief proposal would temporarily lower what millions of Marketplace enrollees and uninsured potential enrollees would pay toward premiums and would provide states that have not expanded their Medicaid programs a financial boost that would more than offset their costs initially, two new KFF analyses find. The analyses assess two parts of the…More

New Incentive for States to Adopt the ACA Medicaid Expansion: Implications for State Spending

The House Energy and Commerce Committee reconciliation proposal as part of the COVID relief package aims to encourage non-expansion states to take up the expansion by providing an additional temporary fiscal incentive for states to newly implement the ACA Medicaid expansion. This brief provides illustrative estimates of the net fiscal benefit to states from these …

New Incentive for States to Adopt the ACA Medicaid Expansion: Implications for State Spending Read More »

MedLumics raises €18 million for atrial fibrillation device

MedLumics has raised another €18 million (around $22 million) to fund clinical trials of its optically-guided imaging system used to guide a surgical procedure for atrial fibrillation (AF) – a serious heart condition that causes an irregular heartbeat.  The Spanish biotech says the latest round – which comes after a $3.8 million first round in …

MedLumics raises €18 million for atrial fibrillation device Read More »

Cash round sets up trial of InteRNA’s microRNA for cancer

Dutch biotech InteRNA Technologies has raised €18.5 million ($22 million) in second-round financing as it prepares to start clinical trials of its lead drug candidate INT-1B3 for solid tumours. The Series B funding has come more than five years after InteRNA’s first-round, which raised just over $10 million in 2015, and nine months after the …

Cash round sets up trial of InteRNA’s microRNA for cancer Read More »

UK biotech investment at record levels amid COVID-19

New figures have confirmed that the UK’s biotech sector received a massive boost from the COVID-19 pandemic last year, with investment levels soaring to £2.8 billion ($3.8 billion) from a level of £1.3 billion in 2019. That makes 2020 a new record year for the sector, exceeding the previous investment high of £2.2 billion in …

UK biotech investment at record levels amid COVID-19 Read More »

Healthcare Financing in 2021 & Medical Cost Trends That May Play An Influence

2020 was undoubtedly a year full of uncertainty and challenges. It showed us how different industries can become vulnerable when unexpected changes occur, but also has provided many brands and businesses with innovative tech-driven solutions to tackle the rising problems. Now in 2021, uncertainty still lingers, but we do know that technology will keep transforming …

Healthcare Financing in 2021 & Medical Cost Trends That May Play An Influence Read More »

Addressing the Risk of Medicare Trust Fund Insolvency

In this Viewpoint for the Journal of the American Medical Association (JAMA), KFF’s Tricia Neuman and co-author Richard G. Frank of Harvard Medical School explain that the looming 2024 insolvency of the Medicare Hospital Insurance Trust Fund cannot be ignored for long.

Donor Government Funding for Family Planning Remains Steady in 2019

A new KFF analysis finds donor government support for global family planning efforts totaled US$1.5 billion in 2019, matching the previous year’s record level and well above the US$1.1 billion in 2012 since the London Summit on Family Planning that created an international goal of increasing family planning services. The funding helps to support a…More

VC fund dedicated to psychedelic meds launches in UK

In the last few years, biopharma companies focusing on psychedelic medicines have been springing up like mushrooms – magic or otherwise – and venture capital money is starting to follow. Today sees the launch of the first investment fund in the UK devoted to psychedelic healthcare, with plans to invest in “revolutionary mind-altering medicines to …

VC fund dedicated to psychedelic meds launches in UK Read More »

Sensyne launches fundraising, agrees patient data deal with Phesi

UK digital health firm Sensyne has secured access to millions more anonymised patent records via an alliance with US clinical trial data specialist Phesi. The new agreement comes after a string of access deals with NHS trusts for patient data, and coincides with a bid by Sensyne to raise £27.5 million (around $37 million) through …

Sensyne launches fundraising, agrees patient data deal with Phesi Read More »

Sensyne launches fundraising, agrees patient data deal with Phesi

UK digital health firm Sensyne has secured access to millions more anonymised patent records via an alliance with US clinical trial data specialist Phesi. The new agreement comes after a string of access deals with NHS trusts for patient data, and coincides with a bid by Sensyne to raise £27.5 million (around $37 million) through …

Sensyne launches fundraising, agrees patient data deal with Phesi Read More »

German biotech CatalYm raises €50 million for GDF-15 inhibitor immunotherapy

CatalYm has closed a €50 million ($59m) series B financing round to fund clinical studies of its immunotherapy targeting Growth Differentiation Factor 15 (GDF-15). The round was led by Vesalius Biocapital III, with participation from Novartis Venture Fund (NVF), Wachstumsfonds Bayern, coparion and founding investors Forbion and BioGeneration Ventures. Founded in 2016 as a spin-out …

German biotech CatalYm raises €50 million for GDF-15 inhibitor immunotherapy Read More »

Kyowa Kirin backs €125m life science fund closed by Fountain Healthcare

Ireland-based Fountain Healthcare Partners has raised another €125 million ($131 million) for its third life sciences fund – 25% ahead of its target – and says it will pump most of the money into European therapeutics and medical device companies. The latest cash injection adds to the €118 million initially raised by Fountain Healthcare for …

Kyowa Kirin backs €125m life science fund closed by Fountain Healthcare Read More »

Sarepta helps bankroll new gene therapy startup AavantiBio

Sarepta chief commercial officer Bo Cumbo has left to head up gene therapy venture – AavantiBio – with $107 million in backing from his former employer and three high-profile life sciences investors. Rare disease specialist Sarepta is putting up $15 million of that first-round financing, with the remainder coming from Perceptive Advisors, Bain Capital Life …

Sarepta helps bankroll new gene therapy startup AavantiBio Read More »

Medicare Accelerated and Advance Payments for COVID-19 Revenue Loss: More Time to Repay

This brief provides an overview and status update of the Medicare accelerated and advance payment program, which provided $100 billion in loans to Medicare providers in the spring of 2020 to compensate for revenue shortfalls due to the coronavirus pandemic. The brief describes who got the funds, and how these loans are distinct from other …

Medicare Accelerated and Advance Payments for COVID-19 Revenue Loss: More Time to Repay Read More »

$110m financing sets up US, Asia expansion for Sophia Genetics

Swiss medical data specialist Sophia Genetics has raised $110 million in an oversubscribed funding round that will be used to boost its headcount and international presence and prepare to take its shares public. Proceeds from the sixth-round of private fundraising will fund the growth in Asia and the US, where it already operates a subsidiary …

$110m financing sets up US, Asia expansion for Sophia Genetics Read More »

Digital health firm Lyra enters unicorn territory after fundraising

Digital health startup Lyra Health has raised $110 million in fourth-round financing, raising its value above the $1 billion threshold for the first time since it was founded five years ago. California-based Lyra provides mental health care services that employers can include in health care plans for their staff, and already features companies like eBay, …

Digital health firm Lyra enters unicorn territory after fundraising Read More »

UK cancer mutation testing firm Biofidelity raises $12m

Cambridge, UK-based Biofidelity has raised $12 million in first-round funding for its cancer diagnosis platform, which can detect mutations quicker than current approaches like gene sequencing. The Series A comes just a few months after Biofidelity launched with seed funding from Longwall Ventures and private backers – as well as multinational diagnostics company Agilent. Barnaby …

UK cancer mutation testing firm Biofidelity raises $12m Read More »

Novo-backed $61m fundraising helps F2G prep for antifungal launch

Anglo-Austrian biotech F2G has raised $60.8 million in venture financing to help it bring a drug for life-threatening fungal infections through late-stage development and onto the market. While these infections remain fairly rare, there is still a pressing need for new antifungals to provide treatment options when established therapies fail, and F2G is one of …

Novo-backed $61m fundraising helps F2G prep for antifungal launch Read More »

Medicare Accelerated and Advance Payments for COVID-19 Revenue Loss: Time to Repay?

This brief provides an overview and status update of the Medicare accelerated and advance payment program, which provided $100 billion in loans to Medicare providers in the spring of 2020 to compensate for revenue shortfalls due to the coronavirus pandemic. The brief describes who got the funds, and how these loans are distinct from other …

Medicare Accelerated and Advance Payments for COVID-19 Revenue Loss: Time to Repay? Read More »

Temporary Enhanced Federal Medicaid Funding Can Soften the Economic Blow of the COVID-19 Pandemic on States, but is Unlikely to Fully Offset State Revenue Declines or Forestall Budget Shortfalls

The temporary boost in federal Medicaid funding enacted as part of the Families First Coronavirus Response Act (FFCRA) will soften the economic blow of COVID-19 on states, but is unlikely to fully offset state revenue declines or forestall budget shortfalls stemming from the pandemic, finds a new KFF analysis. The 6.2 percentage point increase in…More

Take On More Customers Than Ever Before

With Lost Customer Opportunities, Revising Payment Plan Strategies Can Help Your Business Reach More Customers Far too many customers are turned away and declined from services over shortcomings with credit. When you rely on traditional lenders, they only allow you to finance customers with good credit scores, which leaves you unable to provide services to …

Take On More Customers Than Ever Before Read More »

KFF/UNAIDS Analysis Finds Donor Governments Spent US$7.8 Billion for HIV in 2019, Down Almost $200 Million From the Previous Year

Half of the 14 donor governments analyzed in the study decreased their spending on global HIV efforts from 2018 to 2019; six increased; and one held steady. Donor government funding supports HIV care and treatment, prevention and other services in low- and middle-income countries.

How to Save Money on Payment Processing

Are credit card processing fees cutting into your profit margin? Here are some tips to help your business save money. Every time a customer pays for services or products with a credit card, the merchant has to pay a card processing fee. While the fee can often be negligible on a single transaction, the cost …

How to Save Money on Payment Processing Read More »

How can you collect overdue payments and get fair compensation for your services?

The Hidden Costs of Accounts Receivable Many businesses extend credit to customers, to provide the services and products they need.  According to a 2019 report on the economic well-being of U.S. households, 33% of adults are either unable to pay their bills or are one modest financial setback away from hardship. 4 in 10 adults …

How can you collect overdue payments and get fair compensation for your services? Read More »

How to protect yourself from crowdfunding scams before you donate

Protect yourself from crowdfunding scams Many people use crowdfunding platforms like GoFundMe to reach out to their social networks to help pay for much-needed medical treatment. Unfortunately, not every crowdfunding campaign is trustworthy.  While crowdfunding can be a useful way to gather donations for people’s medical and emergency life expenses, it’s also a way to …

How to protect yourself from crowdfunding scams before you donate Read More »

How Automated Payment Solution (APS) boosts collections for your business?

Do you offer simple, fast, and reliable digital interaction to your consumers? Is it possible to convert every customer into a collection opportunity? The answer to this question lies in the financing system used for collecting payments. The need to offer such options occurs due to the evolving mindset of consumers. Nowadays, consumers expect their …

How Automated Payment Solution (APS) boosts collections for your business? Read More »